Ernexa Therapeutics Inc. (ERNA) Tax Provisions (2010 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Tax Provisions came in at -$40000.0 in Q1 2026, down 600.0% YoY from $8000.0 in Q1 2025, and up 35.48% on a QoQ basis from -$62000.0 in Q4 2025.
Ernexa Therapeutics Inc. (ERNA) Tax Provisions (2010 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 17 years of Tax Provisions data on file, last reported at -$40000.0 in Q1 2026.
- Quarterly Tax Provisions fell 600.0% year-over-year to -$40000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$93000.0 (down 1428.57% YoY) and the FY2025 annual result came in at -$45000.0, down 1600.0% from the prior year.
- Tax Provisions improved to -$40000.0 in Q1 2026, from -$62000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $40000.0 in Q4 2022 to a low of -$62000.0 in Q4 2025.
- A 5-year average of -$2666.7 and a median of $4000.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2024 — Tax Provisions jumped 250.0% — and 2026, when it tumbled 600.0%.
- Tracing ERNA's Tax Provisions over 5 years: stood at $40000.0 in 2022, then tumbled by 110.0% to -$4000.0 in 2023, then slumped by 300.0% to -$16000.0 in 2024, then tumbled by 287.5% to -$62000.0 in 2025, then soared by 35.48% to -$40000.0 in 2026.
- The last three Tax Provisions figures came in at -$40000.0 (Q1 2026), -$62000.0 (Q4 2025), and $6000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40,000.00 |
| Dec 31, 2025 | -62,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | -16,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Dec 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | -19,000.00 |
| Mar 31, 2020 | -19,000.00 |
| Dec 31, 2019 | 394,000.00 |